ArticleClinical case reports2026
Neurofibromatosis Type 1 Tumor Involving the Anterosuperior Mediastinum With a Rare c.147C>G Germline Mutation: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder that affects multiple organ systems, most commonly the skin, peripheral nerves, and skeletal system. However, involvement of the anterior mediastinum is rare and has been sporadically reported in the literature. Patients with NF1 have a markedly increased risk of developing malignant peripheral nerve sheath tumors (MPNSTs), which are associated with poor 5-year survival outcomes; therefore, early diagnosis and timely intervention are essential to improving clinical outcomes. We report a case of a solitary neurofibroma located in the anterosuperior mediastinum of a 41-year-old male of Han ethnicity. The tumor was completely resected via uniportal video-assisted thoracoscopic surgery (VATS). Immunohistochemical (IHC) analysis showed positivity for SOX10, S100, CD34, and vimentin, with a Ki-67 proliferation index of < 1%. Genetic analysis of tumor tissue identified two heterozygous nonsense variants in the NF1 gene: c.147C>G (p.Tyr49Ter), a rare pathogenic variant, and c.1318C>T (p.Arg440Ter), a common pathogenic variant. Concurrently, next-generation sequencing of the patient's son's blood sample revealed only the c.147C>G (p.Tyr49Ter) variant. No evidence of recurrence was observed during a 1-year postoperative follow-up. This case underscores the importance of a comprehensive, multidisciplinary approach in the evaluation of mediastinal masses to achieve an accurate diagnosis. Furthermore, it highlights the role of genetic testing in facilitating risk stratification and informing preventive strategies aimed at reducing the risk of progression from NF1 to MPNSTs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.